Ovid Therapeutics Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for OVID, updated each market day.
OVID AI Sentiment
AI sees no strong directional signal for Ovid Therapeutics Inc. Common Stock stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Ovid Therapeutics Inc. Common Stock
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
Sector
Exchange
Market Cap
$434,963,390
Cap Tier
Employees
23
Headquarters
NEW YORK, NY
Listed Since
May 5, 2017
Website
OVID Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
OVID Volatility
Ovid Therapeutics Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
